We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
(+48%)
Cap. Flow
+$442M
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$55.3M |
| 2 |
Apple
AAPL
|
+$33.2M |
| 3 |
Amazon
AMZN
|
+$29.2M |
| 4 |
Microsoft
MSFT
|
+$26.4M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$342M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$93.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$86M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$51.5M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 9.57% |
| 3 | Financials | 8.79% |
| 4 | Industrials | 7.76% |
| 5 | Consumer Discretionary | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Anavex Life Sciences
AVXL
$325M
| $51K | ﹤0.01% |
+10,331
| New | +$39K |
|
3027
Capital City Bank Group
CCBG
$888M
| $51K | ﹤0.01% |
+2,419
| New | +$47.5K |
|
3028
First Bancorp
FNLC
$400M
| $51K | ﹤0.01% |
+2,360
| New | +$48.7K |
|
3029
HealthStream
HSTM
$829M
| $51K | ﹤0.01% |
+2,308
| New | +$53.5K |
|
3030
Nomad Foods
NOMD
$1.59B
| $51K | ﹤0.01% |
2,396
+439
| +22% | +$9.15K |
|
|
NVMI
3031
Nova
NVMI
$12.6B
| $51K | ﹤0.01% |
1,053
+696
| +195% | +$29.6K |
|
3032
Protagonist Therapeutics
PTGX
$9.6B
| $51K | ﹤0.01% |
+2,888
| New | +$36.2K |
|
3033
Tanger
SKT
$4.43B
| $51K | ﹤0.01% |
7,076
-16,942
| -71% | -$112K |
|
|
UBX
3034
DELISTED
Unity Biotechnology
UBX
| $51K | ﹤0.01% |
579
+459
| +383% | +$34K |
|
3035
Energy Fuels
UUUU
$3.69B
| $51K | ﹤0.01% |
33,787
+27,015
| +399% | +$43K |
|
3036
West Bancorporation
WTBA
$496M
| $51K | ﹤0.01% |
2,905
+618
| +27% | +$10.7K |
|
|
CNCE
3037
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $51K | ﹤0.01% |
+5,114
| New | +$49K |
|
|
HMHC
3038
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $51K | ﹤0.01% |
28,189
+16,334
| +138% | +$26.2K |
|
3039
Barings BDC
BBDC
$975M
| $50K | ﹤0.01% |
6,329
-27,354
| -81% | -$196K |
|
3040
CNB Financial Corp
CCNE
$1.02B
| $50K | ﹤0.01% |
+2,802
| New | +$47.4K |
|
|
CRON
3041
Cronos Group
CRON
$1.13B
| $50K | ﹤0.01% |
8,300
+7,840
| +1,704% | +$47.9K |
|
3042
Champions Oncology
CSBR
$69.3M
| $50K | ﹤0.01% |
5,289
+5,097
| +2,655% | +$43.4K |
|
3043
Financial Institutions
FISI
$821M
| $50K | ﹤0.01% |
2,669
+1,487
| +126% | +$25.9K |
|
3044
HCI Group
HCI
$2.29B
| $50K | ﹤0.01% |
+1,090
| New | +$47.2K |
|
3045
MetroCity Bankshares
MCBS
$1.03B
| $50K | ﹤0.01% |
+3,464
| New | +$39.3K |
|
3046
Movado Group
MOV
$822M
| $50K | ﹤0.01% |
4,587
+3,682
| +407% | +$39.7K |
|
3047
NextCure
NXTC
$30.8M
| $50K | ﹤0.01% |
195
+166
| +572% | +$63.2K |
|
3048
Old Second Bancorp
OSBC
$1.29B
| $50K | ﹤0.01% |
+6,380
| New | +$47.2K |
|
3049
Vanguard FTSE Pacific ETF
VPL
$8.42B
| $50K | ﹤0.01% |
782
+677
| +645% | +$40.8K |
|
|
LMPX
3050
DELISTED
LMP Automotive Holdings, Inc. Common Stock
LMPX
| $50K | ﹤0.01% |
+5,133
| New | +$37.1K |
|
Similar funds
CA
BHC
ICP
AP
BWA
JSW
SP
GCM
Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review
As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.
- Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
- Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
- Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
- Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
- Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
- Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
- Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.